questionsmedicales.fr
Maladies endocriniennes
Maladies de la thyroïde
Hyperthyroïdie
Hyperthyroïdie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hyperthyroïdie
Thyroïde
TSH
Scintigraphie
Échographie
Hyperthyroïdie
Symptômes
Hyperthyroïdie
Palpitations
TSH
Hyperthyroïdie
Hormones thyroïdiennes
Diagnostic
Symptômes
Hyperthyroïdie
Symptômes
5
Symptômes
Hyperthyroïdie
Fatigue
Insomnie
Hyperthyroïdie
Troubles du sommeil
Perte de poids
Hyperthyroïdie
Appétit
Exophtalmie
Hyperthyroïdie
Symptômes oculaires
Palpitations
Hyperthyroïdie
Symptômes cardiaques
Prévention
5
Prévention
Hyperthyroïdie
Suivi médical
Antécédents familiaux
Hyperthyroïdie
Facteurs de risque
Stress
Hyperthyroïdie
Facteurs de risque
Alimentation
Hyperthyroïdie
Santé thyroïdienne
Iode
Hyperthyroïdie
Facteurs de risque
Traitements
5
Traitement
Hyperthyroïdie
Médicaments antithyroïdiens
Médicaments
Hyperthyroïdie
Hormones thyroïdiennes
Chirurgie
Hyperthyroïdie
Goitre
Iode radioactif
Hyperthyroïdie
Traitement
Effets secondaires
Hyperthyroïdie
Traitement
Complications
5
Complications
Hyperthyroïdie
Crise thyroïdienne
Problèmes cardiaques
Hyperthyroïdie
Arythmies
Crise thyroïdienne
Hyperthyroïdie
Urgence médicale
Ostéoporose
Hyperthyroïdie
Santé osseuse
Complications psychologiques
Hyperthyroïdie
Anxiété
Facteurs de risque
5
Facteurs de risque
Hyperthyroïdie
Antécédents familiaux
Sexe
Hyperthyroïdie
Facteurs de risque
Maladies auto-immunes
Hyperthyroïdie
Maladie de Graves
Âge
Hyperthyroïdie
Facteurs de risque
Radiothérapie
Hyperthyroïdie
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthyroïdie : Questions médicales les plus fréquentes",
"headline": "Hyperthyroïdie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthyroïdie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthyroïdie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies de la thyroïde",
"url": "https://questionsmedicales.fr/mesh/D013959",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la thyroïde",
"code": {
"@type": "MedicalCode",
"code": "D013959",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thyréotoxicose",
"alternateName": "Thyrotoxicosis",
"url": "https://questionsmedicales.fr/mesh/D013971",
"about": {
"@type": "MedicalCondition",
"name": "Thyréotoxicose",
"code": {
"@type": "MedicalCode",
"code": "D013971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874.397.685"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crise thyréotoxique",
"alternateName": "Thyroid Crisis",
"url": "https://questionsmedicales.fr/mesh/D013958",
"about": {
"@type": "MedicalCondition",
"name": "Crise thyréotoxique",
"code": {
"@type": "MedicalCode",
"code": "D013958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874.397.685.905"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthyroïdie",
"alternateName": "Hyperthyroidism",
"code": {
"@type": "MedicalCode",
"code": "D006980",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Trebillod",
"url": "https://questionsmedicales.fr/author/M%20Trebillod",
"affiliation": {
"@type": "Organization",
"name": "Service d'Endocrinologie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "P Pétrossians",
"url": "https://questionsmedicales.fr/author/P%20P%C3%A9trossians",
"affiliation": {
"@type": "Organization",
"name": "Service d'Endocrinologie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "Priya Vaidyanathan",
"url": "https://questionsmedicales.fr/author/Priya%20Vaidyanathan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC 20010, USA. Electronic address: pvaidyan@childrensnational.org."
}
},
{
"@type": "Person",
"name": "David L Panciera",
"url": "https://questionsmedicales.fr/author/David%20L%20Panciera",
"affiliation": {
"@type": "Organization",
"name": "Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Katie M Boes",
"url": "https://questionsmedicales.fr/author/Katie%20M%20Boes",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lipoprotein(a) is a highly atherogenic lipoprotein: pathophysiological basis and clinical implications.",
"datePublished": "2024-08-13",
"url": "https://questionsmedicales.fr/article/39360655",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HCO.0000000000001170"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37273067",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11883-023-01113-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of lipoprotein(a) with aortic dissection.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35925003",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/clc.23834"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aspirin and lipoprotein(a) in primary prevention.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37527183",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOL.0000000000000891"
}
},
{
"@type": "ScholarlyArticle",
"name": "[State of the art: lipoprotein apheresis].",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990113",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1516-2761"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la thyroïde",
"item": "https://questionsmedicales.fr/mesh/D013959"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hyperthyroïdie",
"item": "https://questionsmedicales.fr/mesh/D006980"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthyroïdie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthyroïdie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthyroïdie",
"description": "Comment diagnostiquer l'hyperthyroïdie ?\nQuels examens sont utilisés pour confirmer l'hyperthyroïdie ?\nQuels symptômes indiquent une hyperthyroïdie ?\nQuel rôle joue la TSH dans le diagnostic ?\nPeut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthyroïdie",
"description": "Quels sont les symptômes courants de l'hyperthyroïdie ?\nL'hyperthyroïdie cause-t-elle des problèmes de sommeil ?\nComment l'hyperthyroïdie affecte-t-elle le poids ?\nY a-t-il des symptômes oculaires associés ?\nL'hyperthyroïdie peut-elle causer des palpitations ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthyroïdie",
"description": "Peut-on prévenir l'hyperthyroïdie ?\nLes antécédents familiaux influencent-ils le risque ?\nLe stress peut-il déclencher l'hyperthyroïdie ?\nUne alimentation équilibrée aide-t-elle ?\nLes carences en iode sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthyroïdie",
"description": "Quels traitements existent pour l'hyperthyroïdie ?\nComment fonctionnent les médicaments antithyroïdiens ?\nQuand est-ce que la chirurgie est nécessaire ?\nL'iode radioactif est-il un traitement efficace ?\nQuels effets secondaires peuvent avoir les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthyroïdie",
"description": "Quelles sont les complications de l'hyperthyroïdie ?\nL'hyperthyroïdie peut-elle causer des problèmes cardiaques ?\nQu'est-ce qu'une crise thyroïdienne ?\nComment l'hyperthyroïdie affecte-t-elle les os ?\nY a-t-il des risques de complications psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthyroïdie",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque d'hyperthyroïdie ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes traitements antérieurs de la thyroïde augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Lipoprotein(a)&page=1#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthyroïdie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de TSH et T4 libre."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour confirmer l'hyperthyroïdie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des scintigraphies thyroïdiennes et des échographies peuvent être réalisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hyperthyroïdie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent perte de poids, nervosité, palpitations et insomnie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la TSH dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une TSH basse indique souvent une hyperthyroïdie, car la thyroïde est hyperactive."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être confirmés par des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hyperthyroïdie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, irritabilité, tremblements et transpiration excessive."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie cause-t-elle des problèmes de sommeil ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des insomnies et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle le poids ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle provoque souvent une perte de poids malgré un appétit accru."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes oculaires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes oculaires comme l'exophtalmie peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie peut-elle causer des palpitations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les palpitations cardiaques sont un symptôme fréquent."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hyperthyroïdie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il déclencher l'hyperthyroïdie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les symptômes, mais n'est pas une cause directe."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée aide-t-elle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne, mais ne prévient pas l'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Les carences en iode sont-elles un facteur de risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'excès d'iode est plus souvent lié à l'hyperthyroïdie que la carence."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hyperthyroïdie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les médicaments antithyroïdiens, l'iode radioactif et la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les médicaments antithyroïdiens ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la production d'hormones thyroïdiennes par la glande thyroïde."
}
},
{
"@type": "Question",
"name": "Quand est-ce que la chirurgie est nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si les autres traitements échouent ou en cas de goitre volumineux."
}
},
{
"@type": "Question",
"name": "L'iode radioactif est-il un traitement efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent utilisé pour détruire les cellules thyroïdiennes hyperactives."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent avoir les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des éruptions cutanées, des douleurs articulaires et des troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hyperthyroïdie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes cardiaques, l'ostéoporose et la crise thyroïdienne."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie peut-elle causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des arythmies et une insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une crise thyroïdienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une urgence médicale avec une augmentation soudaine des hormones thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle les os ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une diminution de la densité osseuse, augmentant le risque d'ostéoporose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications psychologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperthyroïdie peut provoquer anxiété et dépression chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de maladies thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque d'hyperthyroïdie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer une hyperthyroïdie que les hommes."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Graves augmentent le risque d'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 60 ans."
}
},
{
"@type": "Question",
"name": "Les traitements antérieurs de la thyroïde augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements comme la radiothérapie peuvent augmenter le risque d'hyperthyroïdie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Service d'Endocrinologie, CHU Liège, Belgique.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Service d'Endocrinologie, CHU Liège, Belgique.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC 20010, USA. Electronic address: pvaidyan@childrensnational.org.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Karnataka Institute of Medical Sciences, Huballi, India.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Mangalagiri, India, sureshvdrsmailbox@rediffmail.com.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Kamineni Hospital, Hyderabad, India.
Publications dans "Hyperthyroïdie" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia; Medical School, University of Western Australia, Crawley, WA, Australia.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: r.peeters@erasmusmc.nl.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
University of Colorado School of Medicine, Denver, Colorado (M.T.M.).
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of General Surgery, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of General Surgery, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of General Surgery, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Publications dans "Hyperthyroïdie" :
1 publication dans cette catégorie
Affiliations :
Department of General Surgery, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Publications dans "Hyperthyroïdie" :
Lipoprotein(a) has been identified as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis. However, as reviewed here, there is ongoing debate as to the ke...
Genetic analyses have revealed that Lp(a) on a per-particle basis is markedly (about six-fold) more atherogenic than LDL. Oxidized phospholipids carried on Lp(a) have been found to have substantial pr...
Lp(a) is a highly atherogenic lipoprotein and a viable target for intervention in a significant proportion of the general population. Better understanding the basis of its enhanced atherogenicity is i...
Familial hypercholesterolemia (FH) and hyperlipoproteinemia(a) are relatively common disorders, posing a significant health burden due to increased risk of atherosclerotic cardiovascular disease (ASCV...
Availability and indications for lipoprotein apheresis vary across the globe. On average, greater than 60% of atherogenic apoB-containing lipoproteins are immediately reduced following a single proced...
Lipoprotein(a) [Lp(a)] is associated with coronary atherosclerotic heart disease, aortic stenosis, stroke, and heart failure. We aimed to determine the relationship between Lp(a) and aortic dissection...
Two hundred patients with AD were included in our case group. The control group consisted of 200 non-AD people who were age- (±5 years) and gender-matched to the case group. Data were collected retros...
Patients with AD had greater median Lp(a) concentrations than non-AD people (152.50 vs. 81.75 mg/L). Lp(a) was associated with AD in a multivariate logistic regression analysis (odds ratio, 8.03; 95% ...
High levels of Lp(a) are strongly associated with AD, independent of other cardiovascular risk factors....
Lipoprotein(a) [Lp(a)] is causally associated with cardiovascular diseases, and elevated levels are highly prevalent. However, there is a lack of available therapies to address Lp(a)-mediated risk. Th...
Aspirin has been demonstrated to have a clear benefit in secondary prevention of cardiovascular disease, but recent primary prevention trials have at best demonstrated a small benefit. However, indivi...
Individuals with elevated Lp(a) may benefit from aspirin therapy in primary prevention, but further study with plasma Lp(a) levels, broader populations, and randomization of aspirin are needed....
Lipoprotein apheresis (LA) is usually a last resort in cardiovascular high-risk patients in the context of secondary prevention after lifestyle measures and maximal pharmacotherapy have failed to prev...
It is well established that lipoprotein(a)[Lp(a)] and low-density lipoprotein cholesterol (LDL-C) play a vital role in atherosclerosis. We investigated the prevalence and prognostic implications of in...
A total of 9,190 patients with CAD after PCI were consecutively enrolled in the study and subsequently divided into three groups according to baseline LDL-C at cut-off of 70 and 100 mg/dl. Increased L...
During an average of 5.0 y of follow-up, 354 (3.9 %) patients experienced all-cause death with 213(2.3 %) of whom from cardiac death. Increased Lp(a) was present in 25.7 %, 34.2 %, and 40.6 % across t...
We confirmed that increased Lp(a) was associated with increased risk of long-term outcomes, and such an association was modified by the baseline LDL-C concentrations. Screening of high Lp(a) in indivi...
To review evidence of existing and new pharmacological therapies for lowering lipoprotein(a) (Lp[a]) concentrations and their impact on clinically relevant outcomes....
We searched for literature pertaining to Lp(a) and pharmacological treatments in PubMed. We reviewed articles published between 1963 and 2020....
We found that statins significantly increased Lp(a) concentrations. Therapies that demonstrated varying degrees of Lp(a) reduction included ezetimibe, niacin, proprotein convertase subtilisin/kexin ty...
There are multiple lipid-lowering agents currently being used to treat hyperlipidemia that also have a Lp(a)-lowering effect. Two RNA therapies specifically targeted to lower Lp(a) are being investiga...
There is abundant evidence that elevated lipoprotein(a) [LP(a)] associates with cardiovascular risk. Most lipid modifying therapies don't reduce Lp(a), but new technologies are emerging that act upstr...
Despite the benefit of therapies for the prevention of atherosclerotic cardiovascular disease (ASCVD), Lp(a) is one of the 'residual risks,' established by observational and Mendelian randomization st...
New Lp(a) lowering therapies have the potential to contribute to the personalized prevention of ASCVD....
Plasma low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp(a)) are both associated with coronary heart disease (CHD). This study investigated whether elevated plasma Lp(a) concentration...
Participants from the Multi-Ethnic Study of Atherosclerosis (MESA) (n = 4,585) were categorized into four groups: Group 1: LDL-C ≤ 100 mg/dL, Lp(a) < 50 mg/dL; Group 2: LDL-C > 100 mg/dL, Lp(a) < 50 m...
Participants were followed for a mean of 13.4 years and a total of 315 CHD events occurred. Compared to participants with LDL-C ≤ 100 mg/dL and Lp(a) < 50 mg/dL, those with LDL-C > 100 mg/dL and Lp(a)...
When Lp(a) was elevated, risk of CHD events increased, regardless of baseline LDL-C....
Approximately 5 % of the population have highly elevated levels of lipoprotein(a) (Lp(a)), which is a genetically determined risk factor for cardiovascular disease. Measuring lipoprotein(a) can improv...